Recommended Pages at novartis.com
Novartis: Be Healthy
novartis.com — “Novartis is dedicated to enhancing the health and well-being of employees” View full resource at novartis.com
Most Recently Shared on April 4, 2012 at 7:09 am By:
April 7 is World Health Day: #Novartis provides opportunities for associates to take control of their personal healh http://t.co/y2bohNMa
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug Glivec® for three years after surgery
novartis.com — “Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug Glivec® for three years after surgery” View full resource at novartis.com
Most Recently Shared on March 27, 2012 at 8:29 pm By:
Check out the newly published #GIST data in today’s edition of the #JAMA http://t.co/NphMWIIM
Glivec patent case in India
novartis.com — “Fact and fiction about the Glivec patent case in India” View full resource at novartis.com
Most Recently Shared on February 17, 2012 at 8:10 pm By:
#Didyouknow #Novartis provides free patient assistance to #CML & GIST patients http://t.co/fel31yJK
CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery
novartis.com — “CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery” View full resource at novartis.com
Most Recently Shared on January 20, 2012 at 3:05 pm By:
Novartis drug receives a positive opinion from #CHMP http://t.co/wct0x0q5
Novartis drug Signifor® recommended by CHMP for EU approval to treat patients with Cushing's disease
novartis.com — “Novartis drug Signifor® recommended by CHMP for EU approval to treat patients with Cushing's disease” View full resource at novartis.com
Most Recently Shared on January 20, 2012 at 1:02 pm By:
CHMP recommends approval of new treatment for debilitating endocrine disorder http://t.co/aM4Fp1S5
Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US while Novartis Group strengthens quality standards across all manufacturing sites
novartis.com — “Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US while Novartis Group strengthens quality standards across all manufacturing sites” View full resource at novartis.com
Most Recently Shared on January 9, 2012 at 4:19 am By:
HospiScript Services Health Organization
Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US http://t.co/nB2t9cdn
The Novartis Malaria Initiative: lessons from a dramatic decade
novartis.com — “The Novartis Malaria Initiative: lessons from a dramatic decade” View full resource at novartis.com
Most Recently Shared on October 3, 2011 at 8:00 am By:
For more info on Novartis Malaria Initiative visit http://t.co/LZiEh1kF
Novartis study shows QTI571 significantly improved walking distance in patients with life-threatening pulmonary arterial hypertension
novartis.com — “Novartis study shows QTI571 significantly improved walking distance in patients with life-threatening pulmonary arterial hypertension” View full resource at novartis.com
Most Recently Shared on September 25, 2011 at 11:14 am By:
Novartis announces Phase III data in #pah patients being presented at the #ers2011 Annual Congress http://t.co/YFFc5IlG
Glivec patent case in India
novartis.com — “Fact and fiction about the Glivec patent case in India” View full resource at novartis.com
Most Recently Shared on September 9, 2011 at 2:22 pm By:
Learn the facts about the Novartis Glivec case in India http://t.co/WJLFkvx
Novartis receives EU approval for Votubia®, the first medication to treat children and adults with SEGA associated with TSC
novartis.com — “Novartis receives EU approval for Votubia®, the first medication to treat children and adults with SEGA associated with TSC” View full resource at novartis.com
Most Recently Shared on September 8, 2011 at 5:35 am By:
Novartis drug granted approval in #EuropeanUnion http://t.co/V4jW5VA
FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis
novartis.com — “FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis” View full resource at novartis.com
Most Recently Shared on August 29, 2011 at 1:51 pm By:
eyeonfda Pharma and Health Lawyer
#FDA issues CRL Novartis drug ACZ885 for the treatment of gouty arthritis requesting add'l clinical data - http://ow.ly/6fqYT
Novartis International BioCamp spotlights how diversity spurs innovation across the company and inspires future science leaders
novartis.com — “Novartis International BioCamp spotlights how diversity spurs innovation across the company and inspires future science leaders” View full resource at novartis.com
Most Recently Shared on August 29, 2011 at 8:01 am By:
Novartis International #BioCamp spotlights how diversity spurs innovation across the company http://t.co/Y0pzyNy
Novartis drug Afinitor® recommended by CHMP for EU approval to treat patients with advanced pancreatic neuroendocrine tumors
novartis.com — “Novartis drug Afinitor® recommended by CHMP for EU approval to treat patients with advanced pancreatic neuroendocrine tumors” View full resource at novartis.com
Most Recently Shared on July 22, 2011 at 5:04 pm By:
#CHMP recommends new treatment for difficult-to-treat cancer http://t.co/TkSUBsb
Novartis delivers strong financial results and four major approvals in second quarter of 2011
novartis.com — “Novartis delivers strong financial results and four major approvals in second quarter of 2011” View full resource at novartis.com
Most Recently Shared on July 19, 2011 at 5:26 am By:
Novartis has released its Q2 financial results http://t.co/EYe7Crq
Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers for 2011-2012 influenza season
novartis.com — “Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers for 2011-2012 influenza season” View full resource at novartis.com
Most Recently Shared on July 15, 2011 at 8:38 pm By:
eyeonfda Pharma and Health Lawyer
Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers for 2011-2012 influenza season - http://ow.ly/5FKAq
